Q/C Technologies, Inc. Accounts Receivable, Related Parties, Current
Q/C Technologies, Inc. (QCLS) had Accounts Receivable, Related Parties, Current of $125.00 thousand as of 2017-12-31, per its 10-K filed 2018-04-03.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2018-07-13
- 2017-12-31: Accounts Receivable, Related Parties, Current $125.00K.
- 2017-09-30: Accounts Receivable, Related Parties, Current $125.00K.
- 2017-06-30: Accounts Receivable, Related Parties, Current $125.00K.
- 2017-03-31: Accounts Receivable, Related Parties, Current $24.43K.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2017-12-31 | $125.00K 10-K · filed 2018-04-03 |
| 2017-09-30 | $125.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $125.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $24.43K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $31.89K 10-Q/A · filed 2018-07-13 |
| 2016-09-30 | $31.89K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $31.89K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $31.52K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $31.51K 10-K · filed 2017-04-11 |
| 2015-03-31 | $864.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $864.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $1.48M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.48M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.48M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.21M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |